DOCSLIB.ORG

The Securities and Exchange Commission Has Not Necessarily Reviewed the Information in This Filing and Has Not Determined If It Is Accurate and Complete

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Securities and Exchange Commission Has Not Necessarily Reviewed the Information in This Filing and Has Not Determined If It Is Accurate and Complete The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. The reader should not assume that the information is accurate and complete. OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0006 Washington, D.C. 20549 Oct 31, FORM 13F Expires: 2018 FORM 13F COVER PAGE Estimated average burden hours per 23.8 response: Report for the Calendar Year or Quarter Ended: 09-30-2020 Check here if Amendment Amendment Number: This Amendment (Check only one.): is a restatement. adds new holdings entries. Institutional Investment Manager Filing this Report: Name: The PNC Financial Services Group, Inc. Address: The Tower at PNC Plaza 300 Fifth Avenue Pittsburgh, PA 15222-2401 Form 13F File Number: 028-01235 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Gregory H. Kozich Title: Senior Vice President & Controller Phone: (888) 762-2265 Signature, Place, and Date of Signing: /s/ Gregory H. Kozich Pittsburgh, PA 11-06-2020 [Signature] [City, State] [Date] Report Type (Check only one.): X 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) Form 13F Summary Page Report Summary: Number of Other Included Managers: 4 Form 13F Information Table Entry Total: 3,871 Form 13F Information Table Value Total: 65,574,705 (thousands) List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. [If there are no entries in this list, state “NONE” and omit the column headings and list entries.] Form 13F File No. Name Number 2 028-5284 PNC Bank, National Association 3 028-13605 PNC Capital Advisors, LLC 4 028-13663 PNC Delaware Trust Company 5 028-16415 PNC Investments LLC The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. The reader should not assume that the information is accurate and complete. OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0006 Washington, D.C. 20549 Oct 31, FORM 13F Expires: 2018 FORM 13F INFORMATION TABLE Estimated average burden hours per 23.8 response: COLUMN COLUMN COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 5 COLUMN 6 COLUMN 8 4 7 VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE DEUTSCHE BANK A G NAMEN AKT D18190898 62 7,356 SH DFND 2 7,356 0 0 DEUTSCHE BANK A G NAMEN AKT D18190898 83 9,853 SH DFND 2 9,853 0 0 DEUTSCHE BANK A G NAMEN AKT D18190898 83 9,853 SH OTR 2 9,853 0 0 DEUTSCHE BANK A G NAMEN AKT D18190898 2 241 SH DFND 4 241 0 0 ADIENT PLC ORD SHS G0084W101 34 1,941 SH DFND 2 1,941 0 0 ADIENT PLC ORD SHS G0084W101 19 1,123 SH DFND 2 1,123 0 0 ADIENT PLC ORD SHS G0084W101 19 1,123 SH OTR 2 1,123 0 0 ADIENT PLC ORD SHS G0084W101 14 795 SH DFND 3 795 0 0 ADIENT PLC ORD SHS G0084W101 2 95 SH DFND 4 95 0 0 ALLEGION PLC ORD SHS G0176J109 2,879 29,108 SH DFND 2 29,108 0 0 ALLEGION PLC ORD SHS G0176J109 420 4,243 SH DFND 2 3,642 0 601 ALLEGION PLC ORD SHS G0176J109 420 4,243 SH OTR 2 3,642 0 601 ALLEGION PLC ORD SHS G0176J109 6 59 SH DFND 3 59 0 0 ALLEGION PLC ORD SHS G0176J109 41 416 SH DFND 4 416 0 0 ALLEGION PLC ORD SHS G0176J109 71 713 SH DFND 4 713 0 0 ALLEGION PLC ORD SHS G0176J109 71 713 SH OTR 4 713 0 0 ALKERMES PLC SHS G01767105 26 1,599 SH DFND 2 1,599 0 0 ALKERMES PLC SHS G01767105 0 20 SH DFND 2 20 0 0 ALKERMES PLC SHS G01767105 0 20 SH OTR 2 20 0 0 AMCOR PLC ORD G0250X107 711 64,352 SH DFND 2 64,352 0 0 AMCOR PLC ORD G0250X107 638 57,779 SH DFND 2 57,779 0 0 AMCOR PLC ORD G0250X107 638 57,779 SH OTR 2 57,779 0 0 AMCOR PLC ORD G0250X107 11 1,033 SH DFND 3 1,033 0 0 AMCOR PLC ORD G0250X107 14 1,277 SH DFND 4 1,277 0 0 AMCOR PLC ORD G0250X107 1 82 SH DFND 4 82 0 0 AMCOR PLC ORD G0250X107 1 82 SH OTR 4 82 0 0 AMDOCS LTD SHS G02602103 190 3,315 SH DFND 2 3,315 0 0 AMDOCS LTD SHS G02602103 226 3,937 SH DFND 2 697 0 3,240 AMDOCS LTD SHS G02602103 226 3,937 SH OTR 2 697 0 3,240 AMDOCS LTD SHS G02602103 1 20 SH DFND 4 20 0 0 AMDOCS LTD SHS G02602103 1 20 SH OTR 4 20 0 0 AMBARELLA INC SHS G037AX101 196 3,764 SH DFND 2 3,764 0 0 AMBARELLA INC SHS G037AX101 4 83 SH DFND 2 83 0 0 AMBARELLA INC SHS G037AX101 4 83 SH OTR 2 83 0 0 AON PLC SHS CL A G0403H108 22,387 108,519 SH DFND 2 107,203 0 1,316 AON PLC SHS CL A G0403H108 7,179 34,801 SH DFND 2 34,801 0 0 AON PLC SHS CL A G0403H108 7,179 34,801 SH OTR 2 34,801 0 0 AON PLC SHS CL A G0403H108 32 154 SH DFND 3 154 0 0 AON PLC SHS CL A G0403H108 833 4,036 SH DFND 4 4,036 0 0 AON PLC SHS CL A G0403H108 44 214 SH DFND 4 214 0 0 AON PLC SHS CL A G0403H108 44 214 SH OTR 4 214 0 0 ARCH CAP GROUP LTD ORD G0450A105 1,740 59,504 SH DFND 2 59,504 0 0 ARCH CAP GROUP LTD ORD G0450A105 128 4,387 SH DFND 2 4,387 0 0 ARCH CAP GROUP LTD ORD G0450A105 128 4,387 SH OTR 2 4,387 0 0 ARCH CAP GROUP LTD ORD G0450A105 5 163 SH DFND 4 163 0 0 ARGO GROUP INTL COM G0464B107 1 30 SH DFND 2 30 0 0 HLDGS LTD ASSURED GUARANTY COM G0585R106 3 150 SH DFND 2 150 0 0 LTD ASSURED GUARANTY COM G0585R106 14 641 SH DFND 2 641 0 0 LTD ASSURED GUARANTY COM G0585R106 14 641 SH OTR 2 641 0 0 LTD ATLASSIAN CORP PLC CL A G06242104 4,707 25,894 SH DFND 2 25,894 0 0 ATLASSIAN CORP PLC CL A G06242104 2,824 15,533 SH DFND 2 13,418 0 2,115 ATLASSIAN CORP PLC CL A G06242104 2,824 15,533 SH OTR 2 13,418 0 2,115 ATLASSIAN CORP PLC CL A G06242104 3 18 SH DFND 4 18 0 0 ATHENE HOLDING LTD CL A G0684D107 30 873 SH DFND 2 873 0 0 ATHENE HOLDING LTD CL A G0684D107 2 61 SH DFND 2 61 0 0 ATHENE HOLDING LTD CL A G0684D107 2 61 SH OTR 2 61 0 0 AXIS CAP HLDGS LTD SHS G0692U109 8 193 SH DFND 2 193 0 0 AXIS CAP HLDGS LTD SHS G0692U109 3 72 SH DFND 2 72 0 0 AXIS CAP HLDGS LTD SHS G0692U109 3 72 SH OTR 2 72 0 0 AXALTA COATING SYS COM G0750C108 23 1,033 SH DFND 2 1,033 0 0 LTD AXALTA COATING SYS COM G0750C108 3 125 SH DFND 4 125 0 0 LTD AXOVANT SCIENCES COM G0750W203 1 125 SH DFND 2 125 0 0 LTD ATLANTICA SHS G0751N103 0 16 SH DFND 2 16 0 0 SUSTAINABLE INFR P ATLANTICA SHS G0751N103 528 18,450 SH DFND 2 18,450 0 0 SUSTAINABLE INFR P ATLANTICA SHS G0751N103 528 18,450 SH OTR 2 18,450 0 0 SUSTAINABLE INFR P BANK OF NT SHS NEW G0772R208 5 211 SH DFND 2 211 0 0 BUTTERFIELD&SON L BANK OF NT SHS NEW G0772R208 1 60 SH DFND 2 60 0 0 BUTTERFIELD&SON L BANK OF NT SHS NEW G0772R208 1 60 SH OTR 2 60 0 0 BUTTERFIELD&SON L BIOHAVEN PHARMACTL COM G11196105 109 1,670 SH DFND 2 1,670 0 0 HLDG CO L BIOHAVEN PHARMACTL COM G11196105 2 26 SH DFND 2 26 0 0 HLDG CO L BIOHAVEN PHARMACTL COM G11196105 2 26 SH OTR 2 26 0 0 HLDG CO L ACCENTURE PLC SHS CLASS A G1151C101 74,214 328,397 SH DFND 2 322,405 0 5,992 IRELAND ACCENTURE PLC SHS CLASS A G1151C101 20,972 92,801 SH DFND 2 87,306 0 5,495 IRELAND ACCENTURE PLC SHS CLASS A G1151C101 20,972 92,801 SH OTR 2 87,306 0 5,495 IRELAND ACCENTURE PLC SHS CLASS A G1151C101 65,561 290,105 SH DFND 3 288,855 0 1,250 IRELAND ACCENTURE PLC SHS CLASS A G1151C101 8,019 35,483 SH DFND 3 35,437 0 46 IRELAND ACCENTURE PLC SHS CLASS A G1151C101 8,019 35,483 SH OTR 3 35,437 0 46 IRELAND ACCENTURE PLC SHS CLASS A G1151C101 853 3,773 SH DFND 4 3,773 0 0 IRELAND ACCENTURE PLC SHS CLASS A G1151C101 153 679 SH DFND 4 679 0 0 IRELAND ACCENTURE PLC SHS CLASS A G1151C101 153 679 SH OTR 4 679 0 0 IRELAND MIMECAST LTD ORD SHS G14838109 531 11,318 SH DFND 2 11,318 0 0 MIMECAST LTD ORD SHS G14838109 214 4,559 SH DFND 2 199 0 4,360 MIMECAST LTD ORD SHS G14838109 214 4,559 SH OTR 2 199 0 4,360 BROOKFIELD BUSINESS UNIT LTD LP G16234109 1 21 SH DFND 2 21 0 0 PARTNERS BROOKFIELD BUSINESS UNIT LTD LP G16234109 1 21 SH OTR 2 21 0 0 PARTNERS BROOKFIELD BUSINESS UNIT LTD LP G16234109 3 100 SH DFND 4 100 0 0 PARTNERS BROOKFIELD BUSINESS UNIT LTD LP G16234109 3 100 SH OTR 4 100 0 0 PARTNERS BROOKFIELD UNIT LTD PARTN G16249107 6 497 SH DFND 2 497 0 0 PROPERTY PARTRS L BROOKFIELD UNIT LTD PARTN G16249107 4 350 SH DFND 4 350 0 0 PROPERTY PARTRS L BROOKFIELD UNIT LTD PARTN G16249107 4 350 SH OTR 4 350 0 0 PROPERTY PARTRS L BROOKFIELD INFRAST LP INT UNIT G16252101 433 9,099 SH DFND 2 9,099 0 0 PARTNERS BROOKFIELD INFRAST LP INT UNIT G16252101 885 18,587 SH DFND 2 16,937 0 1,650 PARTNERS BROOKFIELD INFRAST LP INT UNIT G16252101 885 18,587 SH OTR 2 16,937 0 1,650 PARTNERS BROOKFIELD INFRAST LP INT UNIT G16252101 490 10,298 SH DFND 4 10,298 0 0 PARTNERS BROOKFIELD PARTNERSHIP UN G16258108 43 813 SH DFND 2 813 0 0 RENEWABLE PARTNER BUNGE LIMITED COM G16962105 41 890 SH DFND 2 890 0 0 BUNGE LIMITED COM G16962105 295 6,448 SH DFND 2 53 0 6,395 BUNGE LIMITED COM G16962105 295 6,448 SH OTR 2 53 0 6,395 BUNGE LIMITED COM G16962105 3 65 SH DFND 4 65 0 0 BUNGE LIMITED COM G16962105 3 65 SH OTR 4 65 0 0 CALEDONIA MNG CORP SHS NEW G1757E113
Load more

Recommended publications
  • List of Marginable OTC Stocks
    List of Marginable OTC Stocks @ENTERTAINMENT, INC. ABACAN RESOURCE CORPORATION ACE CASH EXPRESS, INC. $.01 par common No par common $.01 par common 1ST BANCORP (Indiana) ABACUS DIRECT CORPORATION ACE*COMM CORPORATION $1.00 par common $.001 par common $.01 par common 1ST BERGEN BANCORP ABAXIS, INC. ACETO CORPORATION No par common No par common $.01 par common 1ST SOURCE CORPORATION ABC BANCORP (Georgia) ACMAT CORPORATION $1.00 par common $1.00 par common Class A, no par common Fixed rate cumulative trust preferred securities of 1st Source Capital ABC DISPENSING TECHNOLOGIES, INC. ACORN PRODUCTS, INC. Floating rate cumulative trust preferred $.01 par common $.001 par common securities of 1st Source ABC RAIL PRODUCTS CORPORATION ACRES GAMING INCORPORATED 3-D GEOPHYSICAL, INC. $.01 par common $.01 par common $.01 par common ABER RESOURCES LTD. ACRODYNE COMMUNICATIONS, INC. 3-D SYSTEMS CORPORATION No par common $.01 par common $.001 par common ABIGAIL ADAMS NATIONAL BANCORP, INC. †ACSYS, INC. 3COM CORPORATION $.01 par common No par common No par common ABINGTON BANCORP, INC. (Massachusetts) ACT MANUFACTURING, INC. 3D LABS INC. LIMITED $.10 par common $.01 par common $.01 par common ABIOMED, INC. ACT NETWORKS, INC. 3DFX INTERACTIVE, INC. $.01 par common $.01 par common No par common ABLE TELCOM HOLDING CORPORATION ACT TELECONFERENCING, INC. 3DO COMPANY, THE $.001 par common No par common $.01 par common ABR INFORMATION SERVICES INC. ACTEL CORPORATION 3DX TECHNOLOGIES, INC. $.01 par common $.001 par common $.01 par common ABRAMS INDUSTRIES, INC. ACTION PERFORMANCE COMPANIES, INC. 4 KIDS ENTERTAINMENT, INC. $1.00 par common $.01 par common $.01 par common 4FRONT TECHNOLOGIES, INC.
    [Show full text]
  • New Opportunties - TF
    New Opportunties - TF Schedule of Investments as of 2017-09-30 (Unaudited) Holding Shares/Principal Amount Market Value ($) Cotiviti Holdings Inc 82,434 2,965,975 LogMeIn Inc 26,688 2,937,014 CDW Corp/DE 44,273 2,922,018 Tivity Health Inc 65,176 2,659,181 XPO Logistics Inc 38,536 2,611,970 Burlington Stores Inc 26,646 2,543,627 Ball Corp 58,574 2,419,106 RingCentral Inc 57,626 2,405,886 Bright Horizons Family Solutions Inc 27,768 2,393,879 MSCI Inc 20,395 2,384,176 Catalent Inc 58,551 2,337,356 CyrusOne Inc 39,336 2,318,070 Dolby Laboratories Inc 38,884 2,236,608 Granite Construction Inc 38,149 2,210,735 SiteOne Landscape Supply Inc 37,779 2,194,960 CBOE Holdings Inc 20,195 2,173,588 2U Inc 38,578 2,161,911 LKQ Corp 59,115 2,127,549 Summit Materials Inc 66,267 2,122,532 AAR Corp 56,143 2,121,083 Planet Fitness Inc 78,462 2,116,905 Callidus Software Inc 83,778 2,065,128 Mercury Systems Inc 39,658 2,057,457 Pool Corp 18,587 2,010,556 Fortune Brands Home & Security Inc 29,197 1,962,914 Brunswick Corp/DE 34,991 1,958,446 Brink's Co/The 23,134 1,949,040 Cooper Cos Inc/The 8,214 1,947,622 Chegg Inc 131,125 1,945,895 Tyler Technologies Inc 11,070 1,929,722 KLX Inc 36,290 1,920,830 Paycom Software Inc 25,177 1,887,268 WABCO Holdings Inc 12,660 1,873,680 Advanced Disposal Services Inc 72,336 1,822,144 Essent Group Ltd 44,825 1,815,412 Installed Building Products Inc 28,011 1,815,113 John Bean Technologies Corp 17,938 1,813,532 Alarm.com Holdings Inc 39,789 1,797,667 ITT Inc 40,325 1,785,188 Acadia Healthcare Co Inc 37,106 1,772,183 Broadridge
    [Show full text]
  • Say on Pay Results (As of September 5)
    THIS REPORT CAN BE ACCESSED AT HTTP://WWW.SEMLERBROSSY.COM/SAYONPAY NOTE: THIS WILL BE OUR FINAL SAY ON PAY UPDATE FOR 2012. WE WILL ISSUE A FULL REPORT PROVIDING RESULTS FOR THE ENTIRE 2012 PROXY SEASON IN JANUARY 2013. PLEASE CONTINUE TO VISIT OUR SAY ON PAY BLOG FOR UPDATES. SAY ON PAY RESULTS 2012 RUSSELL 3000 SEPTEMBER 5 2012 SAY ON PAY RESULTS: RUSSELL 3000 SHAREHOLDER VOTING SUMMARY OF FINDINGS 2012 Vote Results (n=2,025) 2 The majority of companies continue to pass Say on Pay in 2012 with substantial shareholder support: — 1,466 companies (72%) passed with over 90% support — 381 companies (19%) passed with between 70% and 90% support — 125 companies (6%) passed with between 50% and 70% support — 53 companies (2.6%) in the Russell 3000 have failed Vote of the Week McKesson received a vote of 62%, a decline of 8% from 2011, amidst criticism from shareholders and 3 their advisors over high relative CEO pay and retirement benefits Vote Results by Industry Health Care companies have received proportionally less support than other industries, while 4 Consumer Staple and Financial companies have received the most support Vote Results and Market Value 5 There does not appear to be a strong correlation between a company’s market value and Say on Pay vote result How Vote Results Changed in 2012 6 Companies below 70% in 2011 have generally received increased vote support in 2012: — 26 of 30 companies that failed in 2011 have passed in 2012 — Companies between 50‐70% in 2011 have improved by an average of 13% in 2012 Vote results for companies
    [Show full text]
  • Market Cap Close ADV 1598 67Th Pctl 745,214,477.91 $ 23.96
    Market Cap Close ADV 1598 67th Pctl $ 745,214,477.91 $ 23.96 225,966.94 801 33rd Pctl $ 199,581,478.89 $ 10.09 53,054.83 2399 Ticker_ Listing_ Effective_ Revised Symbol Security_Name Exchange Date Mkt Cap Close ADV Stratum Stratum AAC AAC Holdings, Inc. N 20160906 M M M M-M-M M-M-M AAMC Altisource Asset Management Corp A 20160906 L M L L-M-L L-M-L AAN Aarons Inc N 20160906 H H H H-H-H H-H-H AAV Advantage Oil & Gas Ltd N 20160906 H L M H-L-M H-M-M AB Alliance Bernstein Holding L P N 20160906 H M M H-M-M H-M-M ABG Asbury Automotive Group Inc N 20160906 H H H H-H-H H-H-H ABM ABM Industries Inc. N 20160906 H H H H-H-H H-H-H AC Associated Capital Group, Inc. N 20160906 H H L H-H-L H-H-L ACCO ACCO Brand Corp. N 20160906 H L H H-L-H H-L-H ACU Acme United A 20160906 L M L L-M-L L-M-L ACY AeroCentury Corp A 20160906 L L L L-L-L L-L-L ADK Adcare Health System A 20160906 L L L L-L-L L-L-L ADPT Adeptus Health Inc. N 20160906 M H H M-H-H M-H-H AE Adams Res Energy Inc A 20160906 L H L L-H-L L-H-L AEL American Equity Inv Life Hldg Co N 20160906 H M H H-M-H H-M-H AF Astoria Financial Corporation N 20160906 H M H H-M-H H-M-H AGM Fed Agricul Mtg Clc Non Voting N 20160906 M H M M-H-M M-H-M AGM A Fed Agricultural Mtg Cla Voting N 20160906 L H L L-H-L L-H-L AGRO Adecoagro S A N 20160906 H L H H-L-H H-L-H AGX Argan Inc N 20160906 M H M M-H-M M-H-M AHC A H Belo Corp N 20160906 L L L L-L-L L-L-L AHL ASPEN Insurance Holding Limited N 20160906 H H H H-H-H H-H-H AHS AMN Healthcare Services Inc.
    [Show full text]
  • NASDAQ Stock Market
    Nasdaq Stock Market Friday, December 28, 2018 Name Symbol Close 1st Constitution Bancorp FCCY 19.75 1st Source SRCE 40.25 2U TWOU 48.31 21st Century Fox Cl A FOXA 47.97 21st Century Fox Cl B FOX 47.62 21Vianet Group ADR VNET 8.63 51job ADR JOBS 61.7 111 ADR YI 6.05 360 Finance ADR QFIN 15.74 1347 Property Insurance Holdings PIH 4.05 1-800-FLOWERS.COM Cl A FLWS 11.92 AAON AAON 34.85 Abiomed ABMD 318.17 Acacia Communications ACIA 37.69 Acacia Research - Acacia ACTG 3 Technologies Acadia Healthcare ACHC 25.56 ACADIA Pharmaceuticals ACAD 15.65 Acceleron Pharma XLRN 44.13 Access National ANCX 21.31 Accuray ARAY 3.45 AcelRx Pharmaceuticals ACRX 2.34 Aceto ACET 0.82 Achaogen AKAO 1.31 Achillion Pharmaceuticals ACHN 1.48 AC Immune ACIU 9.78 ACI Worldwide ACIW 27.25 Aclaris Therapeutics ACRS 7.31 ACM Research Cl A ACMR 10.47 Acorda Therapeutics ACOR 14.98 Activision Blizzard ATVI 46.8 Adamas Pharmaceuticals ADMS 8.45 Adaptimmune Therapeutics ADR ADAP 5.15 Addus HomeCare ADUS 67.27 ADDvantage Technologies Group AEY 1.43 Adobe ADBE 223.13 Adtran ADTN 10.82 Aduro Biotech ADRO 2.65 Advanced Emissions Solutions ADES 10.07 Advanced Energy Industries AEIS 42.71 Advanced Micro Devices AMD 17.82 Advaxis ADXS 0.19 Adverum Biotechnologies ADVM 3.2 Aegion AEGN 16.24 Aeglea BioTherapeutics AGLE 7.67 Aemetis AMTX 0.57 Aerie Pharmaceuticals AERI 35.52 AeroVironment AVAV 67.57 Aevi Genomic Medicine GNMX 0.67 Affimed AFMD 3.11 Agile Therapeutics AGRX 0.61 Agilysys AGYS 14.59 Agios Pharmaceuticals AGIO 45.3 AGNC Investment AGNC 17.73 AgroFresh Solutions AGFS 3.85
    [Show full text]
  • Fidelity® Total Market Index Fund
    Quarterly Holdings Report for Fidelity® Total Market Index Fund May 31, 2021 STI-QTLY-0721 1.816022.116 Schedule of Investments May 31, 2021 (Unaudited) Showing Percentage of Net Assets Common Stocks – 99.3% Shares Value Shares Value COMMUNICATION SERVICES – 10.1% World Wrestling Entertainment, Inc. Class A (b) 76,178 $ 4,253,780 Diversified Telecommunication Services – 1.1% Zynga, Inc. (a) 1,573,367 17,055,298 Alaska Communication Systems Group, Inc. 95,774 $ 317,970 1,211,987,366 Anterix, Inc. (a) (b) 16,962 838,941 Interactive Media & Services – 5.6% AT&T, Inc. 11,060,871 325,521,434 Alphabet, Inc.: ATN International, Inc. 17,036 805,292 Class A (a) 466,301 1,099,001,512 Bandwidth, Inc. (a) (b) 34,033 4,025,764 Class C (a) 446,972 1,077,899,796 Cincinnati Bell, Inc. (a) 84,225 1,297,065 ANGI Homeservices, Inc. Class A (a) 120,975 1,715,426 Cogent Communications Group, Inc. (b) 66,520 5,028,912 Autoweb, Inc. (a) (b) 6,653 19,028 Consolidated Communications Holdings, Inc. (a) 110,609 1,035,300 Bumble, Inc. 77,109 3,679,641 Globalstar, Inc. (a) (b) 1,067,098 1,707,357 CarGurus, Inc. Class A (a) 136,717 3,858,154 IDT Corp. Class B (a) (b) 31,682 914,343 Cars.com, Inc. (a) 110,752 1,618,087 Iridium Communications, Inc. (a) 186,035 7,108,397 DHI Group, Inc. (a) (b) 99,689 319,005 Liberty Global PLC: Eventbrite, Inc. (a) 114,588 2,326,136 Class A (a) 196,087 5,355,136 EverQuote, Inc.
    [Show full text]
  • Guidelines with Regard to the Composition, Calculation and Management of the Index
    INDEX METHODOLOGY Solactive Pharma Breakthrough Value Index Version 2.1 dated September 03, 2020 Contents Important Information 1. Index specifications 1.1 Short Name and ISIN 1.2 Initial Value 1.3 Distribution 1.4 Prices and Calculation Frequency 1.5 Weighting 1.6 Index Committee 1.7 Publication 1.8 Historical Data 1.9 Licensing 2. Composition of the Index 2.1 Selection of the Index Components 2.2 Ordinary Adjustment 2.3 Extraordinary Adjustment 3. Calculation of the Index 3.1 Index Formula 3.2 Accuracy 3.3 Adjustments 3.4 Dividends and other Distributions 3.5 Corporate Actions 3.6 Correction Policy 3.7 Market Disruption 3.8 Consequences of an Extraordinary Event 4. Definitions 5. Appendix 5.1 Contact Details 5.2 Calculation of the Index – Change in Calculation Method 2 Important Information This document (“Index Methodology Document”) contains the underlying principles and regulations regarding the structure and the operating of the Solactive Pharma Breakthrough Value Index. Solactive AG shall make every effort to implement regulations. Solactive AG does not offer any explicit or tacit guarantee or assurance, neither pertaining to the results from the use of the Index nor the Index value at any certain point in time nor in any other respect. The Index is merely calculated and published by Solactive AG and it strives to the best of its ability to ensure the correctness of the calculation. There is no obligation for Solactive AG – irrespective of possible obligations to issuers – to advise third parties, including investors and/or financial intermediaries, of any errors in the Index.
    [Show full text]
  • UNITED CHURCH of CHRIST, INC. SCHEDULE of INVESTMENTS June 30, 2018 Unaudited - for Information Purposes Only
    THE PENSION BOARDS - UNITED CHURCH OF CHRIST, INC. SCHEDULE OF INVESTMENTS June 30, 2018 Unaudited - for information purposes only. SUMMARY OF INVESTMENTS COST VALUE STABLE VALUE INVESTMENTS Short-Term Investments $ 6,566,917 $ 6,566,917 Fixed Maturity Synthetic Guaranteed Investment Contracts 38,995,288 38,995,288 Constant Duration Synthetic Guaranteed Investment Contracts 126,234,758 126,234,758 TOTAL STABLE VALUE INVESTMENTS $ 171,796,963 $ 171,796,963 SHORT-TERM INVESTMENTS Short-term Investments $ 95,552,274 $ 95,552,274 TOTAL SHORT-TERM INVESTMENTS $ 95,552,274 $ 95,552,274 FIXED-INCOME INVESTMENTS Bonds $ 943,137,735 $ 929,127,457 Bond funds 235,065,068 238,580,280 Asset-backed & Mortgage-backed Securities 167,221,040 162,522,120 TOTAL FIXED-INCOME INVESTMENTS $ 1,345,423,843 $ 1,330,229,857 EQUITY INVESTMENTS Common stocks and equivalents $ 754,559,724 $ 1,047,247,659 Equity funds 364,289,377 398,472,808 Emerging Markets Discounted Assets 100,671,500 86,596,087 TOTAL EQUITY INVESTMENTS $ 1,219,520,601 $ 1,532,316,554 OTHER INVESTMENTS Hedge funds $ 70,137,861 $ 83,227,777 Real Assets 69,437,464 70,498,810 Participation in the United Church Funds, Inc. 38,344,068 42,641,757 TOTAL OTHER INVESTMENTS $ 177,919,393 $ 196,368,344 TOTAL INVESTMENTS $ 3,010,213,074 $ 3,326,263,992 PRINCIPAL INTEREST DESCRIPTION SERIES MATURITY COST VALUE AMOUNT RATE % SHORT-TERM INVESTMENTS MFB NI Treasury Money Market Fund $ 6,566,917 $ 6,566,917 TOTAL SHORT-TERM INVESTMENT $ 6,566,917 $ 6,566,917 FIXED MATURITY SYNTHETIC GUARANTEED INVESTMENT CONTRACTS: Asset-Backed Securities 1,155,548 AEP Texas Central Company 1.98 6/1/2021 $ 1,165,840 $ 1,144,164 1,600,000 Capital One Multi-Asset Execution Trust 1.33 6/15/2022 1,599,615 1,574,914 645,871 Carmax Auto Owner Trust 2016-1 1.61 11/16/2020 645,714 642,237 630,912 CenterPoint Energy, Inc.
    [Show full text]
  • The Weekly Shot Biotech Issue a Weekly Summary of Healthcare Industry Valuation and Near-Term Catalysts June 17, 2010
    Small Cap The Weekly Shot Biotech Issue June 17, 2010 A weekly summary of healthcare industry valuation and near-term catalysts The Weekly Shot: Overview and Comment - Small Cap Biotechnology Next week's sector highlights include LGND’s Thursday analyst event at the Eventi - Pharmaceuticals and Large Cap Biotech Hotel in NYC. The company on 6/15 announced updated 2010 revenue guidance of approx $25M, op ex of approx $30M, and expects to finish the year with $30M - Generics and Specialty Pharmaceuticals in cash (vs approx $43M as of 1Q10). Management will likely focus on partner GSK’s progress with add’l trials of Promacta (for ITP), which could potentially expand the drug’s label to Hep C, AML, and MDS (LGND receives <10% royalty from GSK). Investors should focus on pipeline plans following LGND’s opportunistic 2008/09 M&A activity. Key pipeline programs include LGD-4033 (ph.I, SARM candidate from PCOP) and RG7348, partnered with Roche (ph.I, Hep C candidate from MBRX). We do not expect major data announcements at the event. FDA’s Pediatric Drugs Advisory Committee will meet Monday to discuss pediatric safety reviews of multiple approved drugs, including Kogenate, Casodex, Apidra, NovoLog, Arimidex, Desmopressin, Prevacid, Nexium, Aciphex, Priolex, OraVerse, Zemuron, and Suprane . While important from a public safety perspective, we do not anticipate regulatory activity to be announced. Brian Lian, Ph.D. Small caps biotechs rebounded mid-week as elevated volatility continued across 212.500.6646 [email protected] the broader market. Investors are struggling to balance economic data supporting a modest recovery against concerns on EU debt loads, financial reform legislation, and aggressive govt rhetoric on BP’s oil spill.
    [Show full text]
  • Investment Holdings As of June 30, 2019
    Investment Holdings As of June 30, 2019 Montana Board of Investments | Portfolio as of June 30, 2019 Transparency of the Montana Investment Holdings The Montana Board of Investment’s holdings file is a comprehensive listing of all manager funds, separately managed and commingled, and aggregated security positions. Securities are organized across common categories: Pension Pool, Asset Class, Manager Fund, Aggregated Individual Holdings, and Non-Pension Pools. Market values shown are in U.S. dollars. The market values shown in this document are for the individual investment holdings only and do not include any information on accounts for receivables or payables. Aggregated Individual Holdings represent securities held at our custodian bank and individual commingled accounts. The Investment Holdings Report is unaudited and may be subject to change. The audited Unified Investment Program Financial Statements, prepared on a June 30th fiscal year-end basis, will be made available once the Legislative Audit Division issues the Audit Opinion. Once issued, the Legislative Audit Division will have the Audit Opinion available online at https://www.leg.mt.gov/publications/audit/agency-search-report and the complete audited financial statements will also be available on the Board’s website http://investmentmt.com/AnnualReportsAudits. Additional information can be found at www.investmentmt.com Montana Board of Investments | Portfolio as of June 30, 2019 2 Table of Contents Consolidated Asset Pension Pool (CAPP) 4 CAPP - Domestic Equities 5 CAPP - International
    [Show full text]
  • Immunotherapy Opportunity Emerges for Alzheimer Disease
    RESEARCH HIGHLIGHTS Nature Reviews Drug Discovery | Published online 26 Feb 2016; doi:10.1038/nrd.2016.38 NEURODEGENERATIVE DISEASE Immunotherapy opportunity emerges for Alzheimer disease Although an overactive immune trafficking to the brain, which 1-month interval between sessions, system was thought to be involved promoted clearance of Aβ and reached performance levels com- in the development of Alzheimer improved cognitive function in parable to control mice. Conversely, disease (AD), recent studies have a mouse model of AD. As PD1 when mice that had received a single indicated that boosting the immune checkpoint blockade has been shown session of PD1 blockade were response in the brain might ameliorate to stimulate an IFNγ-dependent examined 2 months later there was disease. Now, writing in Nature immune response in cancer only a marginal improvement in Medicine, Schwartz and colleagues immuno therapy, Schwartz and memory, suggesting that repeated report that immune-checkpoint colleagues set out to explore the treatment sessions are needed to blockade directed against the therapeutic potential of PD1 maintain the beneficial effects. programmed cell death protein 1 blockade in AD. Examination of the brains of (PD1) pathway promotes cerebral To do this, they treated the 5XFAD mice after treatment with amyloid-β (Aβ) clearance and 5 familial AD mutations (5XFAD) the PD1-specific antibody revealed a improves cognitive function in mouse model of AD at 10 months reduction in the cerebral Aβ-plaque mouse models of AD. old (an age at which cerebral pathology load in the hippocampus and in the In a previous study, the authors is advanced) with 2 intraperitoneal cerebral cortex (the main anatomical demonstrated that inhibition of injections of a PD1-specific antibody regions with robust Aβ-plaque forkhead box P3-positive regulatory at 3-day intervals.
    [Show full text]
  • Fourth-Quarter Biotech Job Picture
    CAREERS AND RECRUITMENT Fourth-quarter biotech job picture Michael Francisco he number of biotech sector jobs advertised in the fourth quarter of Finally, the Jackson Laboratory (Bar Harbor, ME, USA) announced a T2011 was down slightly compared with the third quarter, whereas tentative plan to create a center for personalized medicine and genomics pharma sector hiring numbers were similar (Nat. Biotechnol. 29, 1053, in Connecticut. The Jackson Laboratory for Genomic Medicine, to be 2011) as seen in three representative job databases tracked by Nature located near the University of Connecticut Health Center in Farmington, Biotechnology (Tables 1 and 2). would have a budget of about $1.1 billion, with The Jackson Laboratory China continues to attract new investment, as Quintiles Transnational providing $809 million through federal research grants and philanthropy. (Research Triangle Park, NC, USA) launched Kun Tuo, a Beijing-based The center would employ 300 people within the first 10 years and 600 contract research organization providing clinical trial management, employees within 20 years. regulatory submission preparation, biostatistics and data management Fourth-quarter downsizings within the life science industry are shown services to Chinese biotech and pharma companies. Quintiles plans to in Table 3. add 300 employees in China this year. The US Northeast was another hotbed of job growth, with 11 New York–based medical centers coming together with Illumina (San Diego) Table 2 Advertised job openings at the ten largest pharma companies and Roche (Basel) to create the New York Genome Center, a nonprofit Number of advertised openingsb a genomics collaboration that will include the creation of a research facil- Company Number of employees Monster Biospace Naturejobs Johnson & Johnson 119,200 487 12 0 ity in Manhattan in the spring.
    [Show full text]